Feb 4 (Reuters) - Biotech firm Bio-Techne beat analysts' estimates for second-quarter revenue and profit on Wednesday, helped by robust demand for its products used in drug development. The ...
Hosted on MSN
Samsung to spin off Biologics, put biosimilar subsidiary in holding company to boost CDMO
Samsung Group is striving to strengthen its investments and research and development (R&D) in the bio industry by establishing an intermediate holding company for its bio affiliates, spinning off ...
I rate Bio-Rad (BIO) with a buy rating. I start by mentioning that the low growth perspective is the negative aspect. For 2025, the company expects a 0.25% growth rate for its revenues, which might ...
G2 Bio Companies has launched with $200 million in financing from Temasek to develop gene therapy candidates out of the University of Pennsylvania. The company is led by Penn gene therapy expert James ...
The Biotechnology Innovation Organization (BIO) has been plugging away at improving diversity in its member companies for years, setting up and ratifying a group of diversity goals in June 2017. Now, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results